PRAMIPEXOLE DIHYDROCHLORIDE

PRAMIPEXOLE DIHYDROCHLORIDE was reported 4849 times

PRAMIPEXOLE DIHYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IVTH NERVE PARESIS 4 0.1905
1 CEREBRAL HYPOPERFUSION 53 0.1137
2 GAIT SPASTIC 37 0.1079
3 BINOCULAR EYE MOVEMENT DISORDER 31 0.1076
4 RESTLESS LEG AUGMENTATION SYNDROME 16 0.1032
5 GRANULOMA SKIN 68 0.0828
6 CEREBELLAR STROKE 31 0.0793
7 NEEDLE FATIGUE 36 0.0788
8 JEALOUS DELUSION 21 0.0742
9 KLEPTOMANIA 5 0.0685
10 PARAPHILIA 8 0.0615
11 MULTIPLE DRUG THERAPY 46 0.0610
12 DOPAMINE DYSREGULATION SYNDROME 24 0.0538
13 IMPULSE-CONTROL DISORDER 105 0.0510
14 PARKINSONISM HYPERPYREXIA SYNDROME 9 0.0503
15 BLOOD PARATHYROID HORMONE DECREASED 69 0.0465
16 NON-PITTING OEDEMA 4 0.0455
17 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 42 0.0453
18 RELAPSING-REMITTING MULTIPLE SCLEROSIS 38 0.0440
19 PATHOLOGICAL GAMBLING 70 0.0421
20 HYPERSEXUALITY 71 0.0388
21 DELUSION OF PARASITOSIS 5 0.0318
22 PANNICULITIS 70 0.0289
23 AMIMIA 3 0.0273
24 SKIN NEOPLASM EXCISION 21 0.0268
25 TOTAL LUNG CAPACITY DECREASED 41 0.0257
26 COMPULSIVE SHOPPING 52 0.0253
27 RHEUMATOID NODULE 69 0.0250
28 CAMPTOCORMIA 6 0.0250
29 STEREOTYPY 22 0.0233
30 SPEECH SOUND DISORDER 4 0.0233
31 DROPPED HEAD SYNDROME 8 0.0203
32 DRUG TOLERANCE DECREASED 56 0.0199
33 MONOPARESIS 36 0.0199
34 GAMBLING 23 0.0197
35 PNEUMOCOCCAL INFECTION 11 0.0186
36 SUDDEN ONSET OF SLEEP 23 0.0166
37 HYPORESPONSIVE TO STIMULI 19 0.0162
38 CATHETER SITE NODULE 3 0.0157
39 BREATH SOUNDS ABNORMAL 75 0.0152
40 LUNG OPACITY 40 0.0152
41 RHEUMATOID FACTOR POSITIVE 87 0.0150
42 COMPULSIONS 10 0.0150
43 BINGE EATING 16 0.0148
44 MARITAL PROBLEM 8 0.0148
45 NEOPLASM SKIN 23 0.0148
46 PARKINSON'S DISEASE 35 0.0138
47 SKIN NECROSIS 68 0.0131
48 ON AND OFF PHENOMENON 72 0.0130
49 GAMBLING DISORDER 34 0.0126
50 HYPERTONIC BLADDER 36 0.0125
51 PLEURITIC PAIN 34 0.0123
52 BULIMIA NERVOSA 5 0.0114
53 INFUSION SITE SCAR 5 0.0113
54 INFUSION SITE MASS 12 0.0110
55 SLOW RESPONSE TO STIMULI 14 0.0108
56 SLEEP ATTACKS 5 0.0105
57 EXERCISE TOLERANCE DECREASED 60 0.0104
58 BLOOD PRESSURE INADEQUATELY CONTROLLED 61 0.0101
59 HUMIDITY INTOLERANCE 4 0.0100
60 COMPULSIVE SEXUAL BEHAVIOUR 8 0.0099
61 MASKED FACIES 4 0.0099
62 DELUSIONAL DISORDER, PERSECUTORY TYPE 4 0.0095
63 HALLUCINATION, TACTILE 6 0.0090
64 RED BLOOD CELL SEDIMENTATION RATE INCREASED 94 0.0085
65 DERMATILLOMANIA 5 0.0084
66 PERIORBITAL PAIN 7 0.0083
67 STOMA SITE INFLAMMATION 6 0.0080
68 PARKINSONIAN GAIT 5 0.0080
69 TORTICOLLIS 17 0.0080
70 LIBIDO INCREASED 16 0.0079
71 THEFT 5 0.0075
72 DISINHIBITION 12 0.0074
73 INFUSION SITE INDURATION 11 0.0074
74 EFFUSION 10 0.0073
75 RALES 42 0.0072
76 PULMONARY FIBROSIS 137 0.0071
77 INFUSION SITE INFLAMMATION 5 0.0071
78 POSTURE ABNORMAL 23 0.0071
79 CORONARY ARTERY DISSECTION 6 0.0070
80 STOMA SITE INFECTION 9 0.0069
81 STOMA SITE PAIN 10 0.0068
82 DEEP BRAIN STIMULATION 4 0.0066
83 MICTURITION URGENCY 74 0.0065
84 BRONCHIECTASIS 43 0.0064
85 INFUSION SITE DISCHARGE 11 0.0063
86 IMPULSIVE BEHAVIOUR 23 0.0061
87 INFUSION SITE INFECTION 14 0.0060
88 PATIENT-DEVICE INCOMPATIBILITY 4 0.0059
89 NOCTURIA 71 0.0058
90 HYPERCALCAEMIA 72 0.0058
91 PELVIC FLUID COLLECTION 4 0.0057
92 STREPTOCOCCAL BACTERAEMIA 6 0.0055
93 INFUSION SITE NODULE 5 0.0052
94 RESTLESS LEGS SYNDROME 94 0.0052
95 FREEZING PHENOMENON 19 0.0051
96 STOMA SITE DISCHARGE 14 0.0051
97 SPUTUM DISCOLOURED 47 0.0050
98 BLOOD CALCIUM INCREASED 43 0.0049
99 SYNOVITIS 87 0.0048
100 STOMA SITE ERYTHEMA 9 0.0048
101 BASAL CELL CARCINOMA 74 0.0047
102 LUNG HYPERINFLATION 4 0.0047
103 EYELID PAIN 9 0.0044
104 PLEUROTHOTONUS 4 0.0044
105 ULCER 70 0.0044
106 TENOSYNOVITIS 12 0.0043
107 AKINESIA 9 0.0043
108 CATHETER SITE SWELLING 4 0.0043
109 SLEEP-RELATED EATING DISORDER 4 0.0043
110 HYPERKINESIA 9 0.0042
111 CATHETER SITE PAIN 11 0.0042
112 OBSTRUCTIVE AIRWAYS DISORDER 47 0.0042
113 ASPIRATION 46 0.0042
114 DRUG TOLERANCE 21 0.0041
115 HALLUCINATION, VISUAL 87 0.0041
116 DRUG ERUPTION 73 0.0041
117 OBSTRUCTIVE SLEEP APNOEA SYNDROME 6 0.0041
118 BRADYKINESIA 24 0.0041
119 CHOREA 7 0.0041
120 PRESCRIBED UNDERDOSE 80 0.0040
121 INFUSION SITE HAEMORRHAGE 13 0.0039
122 STOMA COMPLICATION 4 0.0039
123 DAYDREAMING 6 0.0039
124 OBSESSIVE THOUGHTS 7 0.0039
125 FRUSTRATION TOLERANCE DECREASED 31 0.0038
126 TROPONIN INCREASED 29 0.0038
127 HYPOMANIA 14 0.0038
128 CARPAL TUNNEL DECOMPRESSION 4 0.0038
129 C-REACTIVE PROTEIN ABNORMAL 24 0.0037
130 OBSESSIVE-COMPULSIVE DISORDER 30 0.0037
131 INFUSION SITE BRUISING 8 0.0037
132 DIABETES MELLITUS INADEQUATE CONTROL 64 0.0036
133 ATAXIA 42 0.0035
134 SLEEP TALKING 6 0.0035
135 DYSKINESIA 139 0.0034
136 DELUSION 53 0.0034
137 BLOOD TEST ABNORMAL 46 0.0033
138 INFUSION SITE WARMTH 4 0.0033
139 ACUTE PSYCHOSIS 8 0.0032
140 INFUSION SITE PRURITUS 10 0.0032
141 INFUSION SITE IRRITATION 4 0.0031
142 MUSCLE RIGIDITY 37 0.0031
143 MUSCLE SPASTICITY 38 0.0031
144 HALLUCINATIONS, MIXED 13 0.0031
145 INFUSION SITE ERYTHEMA 26 0.0031
146 SKIN ULCER 78 0.0030
147 INFUSION SITE REACTION 9 0.0030
148 HYPERPHAGIA 12 0.0030
149 SLEEP DEFICIT 6 0.0028
150 CENTRAL NERVOUS SYSTEM LESION 39 0.0028
151 PERSECUTORY DELUSION 7 0.0028
152 OCULOGYRIC CRISIS 6 0.0028
153 PRODUCT RESIDUE PRESENT 15 0.0028
154 DEVICE ALARM ISSUE 5 0.0028
155 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8 0.0027
156 NEUROLEPTIC MALIGNANT SYNDROME 32 0.0027
157 C-REACTIVE PROTEIN INCREASED 98 0.0027
158 ADRENAL INSUFFICIENCY 32 0.0026
159 HALLUCINATION 197 0.0026
160 CHRONIC RESPIRATORY FAILURE 3 0.0025
161 DYSARTHRIA 91 0.0024
162 CATHETER SITE HAEMORRHAGE 6 0.0024
163 HYPERCAPNIA 7 0.0023
164 CERVICAL SPINAL STENOSIS 4 0.0023
165 CONTRAINDICATED PRODUCT ADMINISTERED 70 0.0023
166 INFUSION SITE PAIN 29 0.0022
167 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 108 0.0022
168 HYPERTHYROIDISM 32 0.0022
169 CARBON DIOXIDE INCREASED 3 0.0022
170 READING DISORDER 5 0.0022
171 GENERAL SYMPTOM 16 0.0021
172 NARCOLEPSY 4 0.0021
173 HEPATITIS 54 0.0021
174 LIVER FUNCTION TEST INCREASED 45 0.0021
175 FEELING COLD 58 0.0021
176 ORAL INTAKE REDUCED 5 0.0021
177 PRESYNCOPE 50 0.0021
178 COLOSTOMY 4 0.0020
179 WHEELCHAIR USER 9 0.0020
180 DEVICE INFUSION ISSUE 5 0.0020
181 MEDICATION ERROR 112 0.0020
182 COGNITIVE DISORDER 94 0.0020
183 DEPRESSIVE SYMPTOM 7 0.0020
184 MUSCULOSKELETAL STIFFNESS 172 0.0020
185 PULMONARY MASS 29 0.0019
186 BLOOD CHLORIDE DECREASED 5 0.0019
187 HAEMOPTYSIS 54 0.0019
188 INFUSION SITE SWELLING 12 0.0019
189 CATHETER SITE ERYTHEMA 4 0.0019
190 BRUXISM 10 0.0019
191 THERAPEUTIC PRODUCT EFFECT DECREASED 83 0.0019
192 TRANSAMINASES INCREASED 41 0.0018
193 SEASONAL ALLERGY 26 0.0018
194 ARTHROPATHY 102 0.0018
195 DEPRESSED MOOD 97 0.0018
196 CHOLECYSTITIS INFECTIVE 5 0.0018
197 MULTIPLE ALLERGIES 14 0.0018
198 NEURALGIA 43 0.0018
199 BLADDER NEOPLASM 3 0.0018
200 PARKINSONISM 17 0.0017
201 DIPLOPIA 45 0.0017
202 MIDDLE INSOMNIA 32 0.0017
203 INFLAMMATION 88 0.0017
204 MOVEMENT DISORDER 54 0.0017
205 SOMNAMBULISM 11 0.0017
206 HYPOXIA 59 0.0017
207 SELF-INJURIOUS IDEATION 7 0.0017
208 PULSE ABNORMAL 4 0.0017
209 BALANCE DISORDER 142 0.0016
210 HALLUCINATION, AUDITORY 26 0.0016
211 HAEMATOLOGICAL INFECTION 4 0.0016
212 PSYCHOMOTOR HYPERACTIVITY 27 0.0016
213 IMMOBILE 7 0.0016
214 ERECTILE DYSFUNCTION 41 0.0016
215 HYPERPARATHYROIDISM SECONDARY 4 0.0016
216 ERYSIPELAS 8 0.0016
217 EXCORIATION 4 0.0016
218 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
219 INFUSION RELATED REACTION 103 0.0016
220 REHABILITATION THERAPY 6 0.0015
221 SKIN WARM 9 0.0015
222 POSTMENOPAUSAL HAEMORRHAGE 4 0.0015
223 OEDEMA PERIPHERAL 187 0.0015
224 VISUAL FIELD DEFECT 11 0.0015
225 SPEECH DISORDER 79 0.0015
226 UPPER RESPIRATORY TRACT INFECTION 69 0.0015
227 ASPARTATE AMINOTRANSFERASE INCREASED 79 0.0015
228 SKIN ABRASION 7 0.0015
229 HEPATIC ENZYME INCREASED 100 0.0015
230 CLUMSINESS 4 0.0015
231 CHANGE OF BOWEL HABIT 3 0.0015
232 TREATMENT NONCOMPLIANCE 79 0.0014
233 RASH PRURITIC 78 0.0014
234 ANAL HAEMORRHAGE 4 0.0014
235 HYPERVOLAEMIA 7 0.0014
236 NECK MASS 4 0.0014
237 FORCED EXPIRATORY VOLUME DECREASED 4 0.0014
238 AORTIC VALVE INCOMPETENCE 6 0.0014
239 OXYGEN SATURATION ABNORMAL 4 0.0014
240 CORONARY ARTERY STENOSIS 7 0.0014
241 ARTHRITIS 109 0.0014
242 ALANINE AMINOTRANSFERASE INCREASED 85 0.0014
243 ORTHOSTATIC HYPOTENSION 24 0.0014
244 HYPOKINESIA 20 0.0014
245 INSURANCE ISSUE 21 0.0014
246 POLLAKIURIA 57 0.0014
247 FEMORAL NECK FRACTURE 7 0.0014
248 WALKING AID USER 9 0.0014
249 FEELING OF BODY TEMPERATURE CHANGE 8 0.0014
250 MOBILITY DECREASED 97 0.0013
251 DIZZINESS POSTURAL 13 0.0013
252 DEAFNESS 35 0.0013
253 AMNESIA 87 0.0013
254 DERMATITIS 28 0.0013
255 METABOLIC ENCEPHALOPATHY 4 0.0013
256 SNORING 5 0.0013
257 MASTICATION DISORDER 4 0.0013
258 BRADYCARDIA 69 0.0013
259 SALIVARY HYPERSECRETION 13 0.0013
260 PERSONALITY CHANGE 12 0.0013
261 PERIPHERAL SWELLING 199 0.0013
262 ABNORMAL BEHAVIOUR 51 0.0013
263 INITIAL INSOMNIA 13 0.0013
264 TRICUSPID VALVE INCOMPETENCE 10 0.0013
265 HUMERUS FRACTURE 6 0.0012
266 MULTIPLE DRUG OVERDOSE INTENTIONAL 4 0.0012
267 DYSTONIA 24 0.0012
268 SUICIDE ATTEMPT 74 0.0012
269 DEVICE OCCLUSION 17 0.0012
270 CONTUSION 116 0.0012
271 SUICIDAL IDEATION 108 0.0012
272 BLOOD PRESSURE DIASTOLIC ABNORMAL 3 0.0012
273 PURULENT DISCHARGE 5 0.0012
274 LOWER RESPIRATORY TRACT INFECTION 53 0.0012
275 VARICOSE VEIN 6 0.0012
276 SKIN INFECTION 13 0.0012
277 BLOOD PRESSURE ABNORMAL 23 0.0012
278 DEPRESSION SUICIDAL 4 0.0012
279 CAROTID ARTERY STENOSIS 4 0.0011
280 ERYTHEMA NODOSUM 4 0.0011
281 SKIN WEEPING 4 0.0011
282 ABDOMINAL MASS 3 0.0011
283 IRON DEFICIENCY 5 0.0011
284 URINARY TRACT DISORDER 5 0.0011
285 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
286 WHEEZING 65 0.0011
287 BLOOD PHOSPHORUS DECREASED 4 0.0011
288 TREMOR 181 0.0011
289 NERVE COMPRESSION 10 0.0011
290 BLOOD CHOLESTEROL ABNORMAL 5 0.0011
291 DRY THROAT 11 0.0011
292 HYPERTENSION 228 0.0011
293 NEURODERMATITIS 4 0.0011
294 BRADYPHRENIA 7 0.0011
295 CHRONIC SINUSITIS 4 0.0011
296 APPETITE DISORDER 7 0.0011
297 PSYCHOTIC DISORDER 31 0.0010
298 CARDIAC VALVE DISEASE 6 0.0010
299 COMMUNICATION DISORDER 4 0.0010
300 PARANOIA 18 0.0010
301 SOCIAL AVOIDANT BEHAVIOUR 6 0.0010
302 THERAPEUTIC PRODUCT EFFECT VARIABLE 4 0.0010
303 HYPOALBUMINAEMIA 8 0.0010
304 BLOOD CREATININE INCREASED 67 0.0010
305 POOR QUALITY SLEEP 22 0.0010
306 AFFECTIVE DISORDER 8 0.0010
307 DECREASED INTEREST 6 0.0010
308 BLOOD UREA INCREASED 17 0.0010
309 BLOOD IRON DECREASED 12 0.0010
310 MYOCLONUS 12 0.0010
311 CEREBRAL ATROPHY 4 0.0010
312 EXTRASYSTOLES 7 0.0010
313 INSOMNIA 267 0.0010
314 WRIST FRACTURE 12 0.0010
315 FLUID INTAKE REDUCED 5 0.0010
316 BONE MARROW DISORDER 3 0.0010
317 DYSPHORIA 5 0.0010
318 MOTOR DYSFUNCTION 10 0.0010
319 TREATMENT FAILURE 81 0.0010
320 MANIA 16 0.0010
321 PRE-EXISTING CONDITION IMPROVED 6 0.0010
322 BLOOD BLISTER 3 0.0010
323 THERAPY NON-RESPONDER 43 0.0010
324 ERECTION INCREASED 4 0.0010
325 JOINT SWELLING 115 0.0010
326 DELIRIUM 33 0.0009
327 PSYCHIATRIC SYMPTOM 7 0.0009
328 INCONTINENCE 10 0.0009
329 GAIT DISTURBANCE 181 0.0009
330 MUSCLE FATIGUE 4 0.0009
331 SLEEP APNOEA SYNDROME 18 0.0009
332 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
333 DYSPHONIA 55 0.0009
334 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
335 ALCOHOLISM 4 0.0009
336 RHEUMATOID ARTHRITIS 106 0.0009
337 COMPRESSION FRACTURE 5 0.0009
338 RESTLESSNESS 34 0.0009
339 BEHAVIOUR DISORDER 5 0.0009
340 FAECALOMA 5 0.0009
341 RENAL FAILURE CHRONIC 7 0.0009
342 THERAPEUTIC RESPONSE DECREASED 55 0.0009
343 PRODUCT COMMUNICATION ISSUE 8 0.0009
344 BLADDER DISORDER 9 0.0009
345 WITHDRAWAL SYNDROME 38 0.0009
346 MULTIPLE SCLEROSIS RELAPSE 62 0.0009
347 BLOOD CREATINE PHOSPHOKINASE INCREASED 26 0.0009
348 PELVIC FRACTURE 7 0.0009
349 CONDITION AGGRAVATED 273 0.0009
350 EATING DISORDER 19 0.0009
351 UNRESPONSIVE TO STIMULI 23 0.0009
352 VASCULAR DEVICE INFECTION 4 0.0009
353 PNEUMONIA ASPIRATION 22 0.0009
354 DRUG INTOLERANCE 85 0.0009
355 AGGRESSION 44 0.0009
356 FALL 292 0.0009
357 EYE PAIN 49 0.0009
358 PRODUCT SUBSTITUTION ISSUE 50 0.0009
359 EYE OPERATION 4 0.0009
360 GAIT INABILITY 29 0.0009
361 PRODUCT DISTRIBUTION ISSUE 8 0.0009
362 PRODUCTIVE COUGH 41 0.0009
363 MULTIPLE MYELOMA 4 0.0009
364 ECONOMIC PROBLEM 13 0.0009
365 CARPAL TUNNEL SYNDROME 12 0.0009
366 SPINAL COMPRESSION FRACTURE 7 0.0008
367 FEELING JITTERY 16 0.0008
368 FAECAL INCONTINENCE 4 0.0008
369 APHAGIA 4 0.0008
370 BRAIN FOG 13 0.0008
371 CAROTID ARTERY OCCLUSION 3 0.0008
372 GASTROOESOPHAGEAL REFLUX DISEASE 66 0.0008
373 PRODUCT USE ISSUE 154 0.0008
374 ANURIA 7 0.0008
375 BODY TEMPERATURE DECREASED 8 0.0008
376 STAPHYLOCOCCAL SEPSIS 4 0.0008
377 URINARY RETENTION 27 0.0008
378 FOOT OPERATION 4 0.0008
379 DIABETIC NEUROPATHY 4 0.0008
380 FEELING DRUNK 6 0.0008
381 CONSTIPATION 176 0.0008
382 PROTEIN URINE PRESENT 4 0.0008
383 OCULAR DISCOMFORT 9 0.0008
384 PNEUMONIA 258 0.0008
385 SWELLING OF EYELID 5 0.0008
386 MITRAL VALVE INCOMPETENCE 9 0.0008
387 CHEMOTHERAPY 3 0.0008
388 CATHETER SITE INFECTION 3 0.0008
389 TOOTH ABSCESS 8 0.0008
390 ALTERED STATE OF CONSCIOUSNESS 17 0.0008
391 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
392 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 55 0.0008
393 INCOHERENT 5 0.0008
394 EYE DISCHARGE 8 0.0008
395 ANGINA UNSTABLE 5 0.0008
396 THERAPY PARTIAL RESPONDER 12 0.0008
397 HYPOTENSION 154 0.0008
398 HYPERSOMNIA 22 0.0008
399 OXYGEN SATURATION DECREASED 43 0.0008
400 WEIGHT FLUCTUATION 8 0.0008
401 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
402 HYPOGAMMAGLOBULINAEMIA 5 0.0008
403 SENSITIVITY TO WEATHER CHANGE 4 0.0008
404 FOOD CRAVING 4 0.0008
405 DYSGRAPHIA 5 0.0008
406 CORONAVIRUS INFECTION 5 0.0008
407 BLOOD PRESSURE DECREASED 50 0.0008
408 NIGHTMARE 26 0.0008
409 BLOOD PRESSURE FLUCTUATION 18 0.0007
410 CANDIDIASIS 3 0.0007
411 OVERWEIGHT 4 0.0007
412 ASTHMA 84 0.0007
413 MEMORY IMPAIRMENT 102 0.0007
414 BLOOD POTASSIUM INCREASED 12 0.0007
415 DECUBITUS ULCER 6 0.0007
416 SPINAL OPERATION 9 0.0007
417 ESCHERICHIA INFECTION 6 0.0007
418 ONYCHOCLASIS 5 0.0007
419 BLOOD COUNT ABNORMAL 11 0.0007
420 CHOKING SENSATION 4 0.0007
421 ABNORMAL DREAMS 20 0.0007
422 CONFUSIONAL STATE 117 0.0007
423 DROOLING 5 0.0007
424 PLEURAL EFFUSION 44 0.0007
425 LYMPHOEDEMA 5 0.0007
426 GASTRIC ULCER HAEMORRHAGE 4 0.0007
427 PULMONARY HYPERTENSION 15 0.0007
428 FORMICATION 5 0.0007
429 DEMENTIA 20 0.0007
430 ABDOMINAL DISCOMFORT 120 0.0007
431 EYE INFECTION 8 0.0007
432 INABILITY TO AFFORD MEDICATION 7 0.0007
433 PERONEAL NERVE PALSY 4 0.0007
434 ROTATOR CUFF SYNDROME 9 0.0007
435 SOMNOLENCE 140 0.0007
436 MYOPATHY 6 0.0007
437 CELLULITIS 35 0.0007
438 PRODUCT ADMINISTRATION ERROR 14 0.0007
439 TONGUE DISORDER 5 0.0007
440 HYPERVENTILATION 4 0.0007
441 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
442 GASTROENTERITIS 10 0.0007
443 DYSSTASIA 20 0.0007
444 MAJOR DEPRESSION 5 0.0007
445 EUPHORIC MOOD 7 0.0007
446 TOOTH INFECTION 9 0.0007
447 RIB FRACTURE 14 0.0007
448 ABDOMINAL DISTENSION 71 0.0007
449 ILLNESS 70 0.0007
450 ADVERSE DRUG REACTION 61 0.0007
451 LIMB DISCOMFORT 21 0.0007
452 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
453 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
454 POST PROCEDURAL COMPLICATION 13 0.0007
455 POOR VENOUS ACCESS 7 0.0007
456 CEREBRAL DISORDER 5 0.0007
457 ABDOMINAL PAIN 157 0.0007
458 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
459 FACIAL PAIN 6 0.0007
460 MACULAR DEGENERATION 8 0.0007
461 ROAD TRAFFIC ACCIDENT 28 0.0007
462 DEPRESSION 152 0.0007
463 HYDRONEPHROSIS 5 0.0007
464 TACHYPNOEA 9 0.0007
465 IMPAIRED GASTRIC EMPTYING 9 0.0007
466 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
467 GASTROINTESTINAL DISORDER 59 0.0007
468 TENSION 4 0.0007
469 BODY HEIGHT DECREASED 7 0.0007
470 AGITATION 48 0.0007
471 BOWEL MOVEMENT IRREGULARITY 5 0.0007
472 RESPIRATORY TRACT INFECTION 17 0.0007
473 INCREASED TENDENCY TO BRUISE 6 0.0007
474 ATRIOVENTRICULAR BLOCK 5 0.0006
475 ARTHRITIS INFECTIVE 3 0.0006
476 URINARY TRACT INFECTION 110 0.0006
477 PULMONARY THROMBOSIS 7 0.0006
478 NEUROPATHY PERIPHERAL 61 0.0006
479 URINARY INCONTINENCE 19 0.0006
480 NASAL DRYNESS 4 0.0006
481 FRACTURE 12 0.0006
482 SPINAL DISORDER 6 0.0006
483 PNEUMOTHORAX 10 0.0006
484 FLUID RETENTION 32 0.0006
485 SCIATICA 10 0.0006
486 HEART RATE DECREASED 22 0.0006
487 NECK PAIN 35 0.0006
488 COUGH 175 0.0006
489 ACUTE RESPIRATORY FAILURE 12 0.0006
490 APATHY 9 0.0006
491 CHOKING 12 0.0006
492 BACK DISORDER 10 0.0006
493 PHARYNGEAL SWELLING 6 0.0006
494 ASPHYXIA 5 0.0006
495 VITREOUS FLOATERS 6 0.0006
496 ADVERSE EVENT 56 0.0006
497 HOSPICE CARE 6 0.0006
498 LIGAMENT SPRAIN 6 0.0006
499 PRODUCT DOSE OMISSION ISSUE 178 0.0006
500 CARDIAC FAILURE ACUTE 4 0.0006
501 FUNGAL INFECTION 20 0.0006
502 TERMINAL STATE 4 0.0006
503 HYPOPHAGIA 15 0.0006
504 PHOTOPHOBIA 11 0.0006
505 DYSPNOEA EXERTIONAL 22 0.0006
506 ECCHYMOSIS 4 0.0006
507 MUSCULOSKELETAL CHEST PAIN 9 0.0006
508 BRONCHITIS 43 0.0006
509 SLEEP DISORDER 41 0.0006
510 HYPOAESTHESIA 86 0.0006
511 ACCIDENTAL OVERDOSE 21 0.0006
512 COORDINATION ABNORMAL 8 0.0006
513 OEDEMA 31 0.0006
514 BLOOD LACTIC ACID INCREASED 3 0.0006
515 HERNIA 11 0.0006
516 SUDDEN DEATH 6 0.0006
517 TENDON RUPTURE 7 0.0006
518 ASTHENIA 213 0.0006
519 BLOOD POTASSIUM DECREASED 17 0.0006
520 OBESITY 9 0.0006
521 HEAD DISCOMFORT 10 0.0006
522 THERMAL BURN 4 0.0006
523 ILEUS 7 0.0006
524 UNDERDOSE 41 0.0006
525 HYPERSENSITIVITY 104 0.0006
526 HIP FRACTURE 18 0.0006
527 GASTROINTESTINAL INFECTION 5 0.0006
528 MUSCULAR WEAKNESS 63 0.0006
529 GASTROENTERITIS VIRAL 10 0.0006
530 OROPHARYNGEAL DISCOMFORT 5 0.0006
531 LIMB INJURY 15 0.0006
532 NEEDLE ISSUE 16 0.0005
533 DRUG INTERACTION 87 0.0005
534 WOUND INFECTION 6 0.0005
535 BLOOD GLUCOSE FLUCTUATION 6 0.0005
536 ERYTHEMA 112 0.0005
537 PNEUMONIA BACTERIAL 5 0.0005
538 DRUG LEVEL INCREASED 9 0.0005
539 FEEDING DISORDER 11 0.0005
540 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
541 CONJUNCTIVITIS 10 0.0005
542 MALNUTRITION 6 0.0005
543 GENERAL PHYSICAL HEALTH DETERIORATION 62 0.0005
544 BEDRIDDEN 7 0.0005
545 DIZZINESS 265 0.0005
546 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
547 INTESTINAL OBSTRUCTION 20 0.0005
548 LEUKAEMIA 5 0.0005
549 IMPAIRED DRIVING ABILITY 6 0.0005
550 DERMATITIS CONTACT 6 0.0005
551 ACIDOSIS 4 0.0005
552 CRYING 19 0.0005
553 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
554 ANXIETY 148 0.0005
555 AFFECT LABILITY 5 0.0005
556 SINUS BRADYCARDIA 5 0.0005
557 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
558 PERIPHERAL COLDNESS 7 0.0005
559 PRODUCT USE IN UNAPPROVED INDICATION 126 0.0005
560 KNEE OPERATION 5 0.0005
561 PRODUCT USE COMPLAINT 8 0.0005
562 SINUSITIS 52 0.0005
563 DYSPHAGIA 48 0.0005
564 PROCEDURAL PAIN 14 0.0005
565 ORAL DISCOMFORT 7 0.0005
566 ACCIDENT 6 0.0005
567 UPPER LIMB FRACTURE 10 0.0005
568 LEUKOCYTOSIS 9 0.0005
569 PRODUCT PHYSICAL ISSUE 10 0.0005
570 MYASTHENIA GRAVIS 4 0.0005
571 INTENTIONAL SELF-INJURY 10 0.0005
572 PANIC ATTACK 18 0.0005
573 PAIN 303 0.0005
574 INFLUENZA 55 0.0005
575 POST PROCEDURAL INFECTION 4 0.0005
576 HEADACHE 305 0.0005
577 PARAESTHESIA ORAL 7 0.0005
578 TEMPERATURE INTOLERANCE 5 0.0005
579 ARTHRALGIA 201 0.0005
580 THINKING ABNORMAL 9 0.0005
581 DISTURBANCE IN ATTENTION 26 0.0005
582 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
583 HYPONATRAEMIA 27 0.0005
584 ALOPECIA 94 0.0005
585 BLEPHAROSPASM 3 0.0005
586 KNEE ARTHROPLASTY 10 0.0005
587 FOOT FRACTURE 9 0.0005
588 HEAD INJURY 15 0.0005
589 CYSTITIS 15 0.0005
590 VITAMIN D DECREASED 4 0.0005
591 BLOOD MAGNESIUM DECREASED 4 0.0005
592 PSYCHOLOGICAL TRAUMA 4 0.0005
593 ATRIAL FIBRILLATION 45 0.0005
594 PYELONEPHRITIS 4 0.0005
595 MULTIPLE SCLEROSIS 22 0.0005
596 BIPOLAR DISORDER 5 0.0005
597 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
598 SKIN LACERATION 5 0.0005
599 SEDATION 12 0.0005
600 DEVICE USE ISSUE 8 0.0005
601 FATIGUE 356 0.0005
602 DISORIENTATION 18 0.0005
603 TOOTH FRACTURE 5 0.0005
604 SOPOR 6 0.0005
605 LETHARGY 26 0.0005
606 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
607 FEAR 12 0.0004
608 DRUG EFFECT DECREASED 24 0.0004
609 BLOOD CALCIUM DECREASED 5 0.0004
610 WEIGHT DECREASED 124 0.0004
611 DYSPNOEA 251 0.0004
612 HYPERHIDROSIS 57 0.0004
613 BODY TEMPERATURE INCREASED 9 0.0004
614 ACUTE MYOCARDIAL INFARCTION 13 0.0004
615 RESPIRATORY TRACT CONGESTION 7 0.0004
616 ANAEMIA 84 0.0004
617 INTERNAL HAEMORRHAGE 5 0.0004
618 HEART RATE INCREASED 43 0.0004
619 UROSEPSIS 4 0.0004
620 RHABDOMYOLYSIS 18 0.0004
621 BACK PAIN 100 0.0004
622 VOMITING 201 0.0004
623 LACERATION 4 0.0004
624 STAPHYLOCOCCAL INFECTION 14 0.0004
625 JOINT INJURY 9 0.0004
626 NERVOUSNESS 22 0.0004
627 GASTRIC ULCER 8 0.0004
628 PAIN IN EXTREMITY 124 0.0004
629 VIRAL INFECTION 14 0.0004
630 RED BLOOD CELL COUNT DECREASED 12 0.0004
631 DEPENDENCE 23 0.0004
632 PARALYSIS 6 0.0004
633 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
634 PSORIATIC ARTHROPATHY 17 0.0004
635 RHINORRHOEA 27 0.0004
636 SEPSIS 46 0.0004
637 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
638 BURSITIS 5 0.0004
639 BLOOD PRESSURE INCREASED 63 0.0004
640 NO THERAPEUTIC RESPONSE 5 0.0004
641 COMPLETED SUICIDE 34 0.0004
642 ABDOMINAL PAIN UPPER 84 0.0004
643 CARDIOMEGALY 5 0.0004
644 PRURITUS 156 0.0004
645 LOSS OF CONSCIOUSNESS 52 0.0004
646 DRUG INEFFECTIVE 534 0.0004
647 DEHYDRATION 54 0.0004
648 SINUS DISORDER 8 0.0004
649 GENERALISED OEDEMA 5 0.0004
650 CATARACT 24 0.0004
651 DEVICE ISSUE 36 0.0004
652 EYE IRRITATION 23 0.0004
653 APHASIA 12 0.0004
654 PYREXIA 137 0.0004
655 OSTEOPENIA 6 0.0004
656 HYPOTHERMIA 4 0.0004
657 MUSCLE ATROPHY 5 0.0004
658 AORTIC ANEURYSM 3 0.0004
659 VERTIGO 24 0.0004
660 COVID-19 69 0.0004
661 SLUGGISHNESS 4 0.0004
662 HIP ARTHROPLASTY 6 0.0004
663 CHEST DISCOMFORT 40 0.0004
664 ANOREXIA 5 0.0004
665 FEMUR FRACTURE 12 0.0004
666 TOOTHACHE 7 0.0004
667 OSTEOMYELITIS 7 0.0004
668 TOOTH LOSS 8 0.0004
669 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
670 NAUSEA 304 0.0004
671 END STAGE RENAL DISEASE 7 0.0004
672 DYSURIA 14 0.0004
673 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
674 OROPHARYNGEAL PAIN 35 0.0004
675 PRODUCT PRESCRIBING ERROR 9 0.0004
676 MIGRAINE 36 0.0004
677 RETCHING 8 0.0004
678 BREAST PAIN 4 0.0004
679 NASAL CONGESTION 22 0.0004
680 SENSORY DISTURBANCE 6 0.0004
681 CARDIAC FAILURE CONGESTIVE 30 0.0004
682 LOCALISED INFECTION 9 0.0004
683 RASH MACULAR 13 0.0004
684 MALAISE 163 0.0004
685 FEELING ABNORMAL 89 0.0004
686 BLOOD SODIUM DECREASED 7 0.0004
687 MENTAL IMPAIRMENT 9 0.0004
688 NEPHROLITHIASIS 17 0.0004
689 FLATULENCE 21 0.0004
690 THROAT TIGHTNESS 10 0.0004
691 PRODUCT TASTE ABNORMAL 5 0.0004
692 DEVICE DISLOCATION 16 0.0004
693 ENCEPHALOPATHY 9 0.0004
694 AKATHISIA 5 0.0004
695 ABNORMAL FAECES 3 0.0004
696 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
697 MUSCLE SPASMS 67 0.0004
698 FLUSHING 37 0.0004
699 CARDIAC DISORDER 34 0.0004
700 SYNCOPE 36 0.0004
701 OFF LABEL USE 314 0.0004
702 HOT FLUSH 27 0.0004
703 NASOPHARYNGITIS 66 0.0004
704 DECREASED APPETITE 83 0.0004
705 KIDNEY INFECTION 7 0.0004
706 ABDOMINAL PAIN LOWER 9 0.0004
707 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
708 CHROMATURIA 8 0.0004
709 REBOUND EFFECT 4 0.0004
710 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
711 HAEMATOCRIT DECREASED 7 0.0004
712 CIRCULATORY COLLAPSE 6 0.0004
713 SPINAL FRACTURE 7 0.0003
714 HAEMATOMA 9 0.0003
715 HYPOKALAEMIA 16 0.0003
716 UNINTENTIONAL MEDICAL DEVICE REMOVAL 4 0.0003
717 MENTAL DISORDER 15 0.0003
718 PARAESTHESIA 54 0.0003
719 EOSINOPHILIA 6 0.0003
720 INFLUENZA LIKE ILLNESS 28 0.0003
721 LYMPHOCYTE COUNT DECREASED 6 0.0003
722 EAR INFECTION 9 0.0003
723 BACTERAEMIA 4 0.0003
724 CARDIAC FAILURE 27 0.0003
725 COLON CANCER 5 0.0003
726 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
727 THROAT IRRITATION 15 0.0003
728 EPISTAXIS 25 0.0003
729 HOSPITALISATION 51 0.0003
730 LIP SWELLING 11 0.0003
731 CORONARY ARTERY DISEASE 10 0.0003
732 LUNG DISORDER 16 0.0003
733 RESPIRATORY DISTRESS 9 0.0003
734 RASH 142 0.0003
735 SMALL INTESTINAL OBSTRUCTION 4 0.0003
736 MUSCULOSKELETAL PAIN 17 0.0003
737 CHILLS 38 0.0003
738 OSTEONECROSIS OF JAW 8 0.0003
739 EYE SWELLING 12 0.0003
740 BACTERIAL INFECTION 6 0.0003
741 HAEMATURIA 11 0.0003
742 DRUG WITHDRAWAL SYNDROME 28 0.0003
743 DERMATITIS ALLERGIC 4 0.0003
744 WEIGHT INCREASED 71 0.0003
745 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
746 INTENTIONAL DOSE OMISSION 9 0.0003
747 PULMONARY OEDEMA 14 0.0003
748 ORAL PAIN 7 0.0003
749 SEROTONIN SYNDROME 6 0.0003
750 LOWER LIMB FRACTURE 6 0.0003
751 SNEEZING 7 0.0003
752 HAEMOGLOBIN DECREASED 32 0.0003
753 GLAUCOMA 6 0.0003
754 THROMBOSIS 25 0.0003
755 SWELLING 29 0.0003
756 RENAL IMPAIRMENT 26 0.0003
757 HIATUS HERNIA 4 0.0003
758 MUSCLE TIGHTNESS 5 0.0003
759 ANAPHYLACTIC REACTION 17 0.0003
760 OSTEOARTHRITIS 13 0.0003
761 VISION BLURRED 42 0.0003
762 INCORRECT DOSE ADMINISTERED BY DEVICE 8 0.0003
763 CHOLELITHIASIS 10 0.0003
764 ANHEDONIA 8 0.0003
765 ORAL CANDIDIASIS 4 0.0003
766 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
767 SARS-COV-2 TEST POSITIVE 4 0.0003
768 DRY EYE 15 0.0003
769 MALIGNANT MELANOMA 4 0.0003
770 JOINT RANGE OF MOTION DECREASED 4 0.0003
771 FULL BLOOD COUNT DECREASED 6 0.0003
772 INFECTION 43 0.0003
773 TYPE 2 DIABETES MELLITUS 10 0.0003
774 CANDIDA INFECTION 5 0.0003
775 PALLOR 8 0.0003
776 THERAPY INTERRUPTED 21 0.0003
777 RENAL FAILURE 39 0.0003
778 FEELING HOT 18 0.0003
779 TACHYCARDIA 26 0.0003
780 SCAR 5 0.0003
781 UNEVALUABLE EVENT 22 0.0003
782 SURGERY 17 0.0003
783 MULTI-ORGAN FAILURE 5 0.0003
784 INTERSTITIAL LUNG DISEASE 14 0.0003
785 MENTAL STATUS CHANGES 8 0.0003
786 INTENTIONAL DRUG MISUSE 6 0.0003
787 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
788 APHONIA 4 0.0003
789 SEIZURE 33 0.0003
790 ABASIA 7 0.0003
791 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 51 0.0003
792 IRRITABILITY 17 0.0003
793 MOOD SWINGS 9 0.0003
794 BRONCHOSPASM 4 0.0003
795 THIRST 5 0.0003
796 SUBDURAL HAEMATOMA 4 0.0003
797 IMPAIRED QUALITY OF LIFE 4 0.0003
798 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
799 CHRONIC KIDNEY DISEASE 21 0.0003
800 SEPTIC SHOCK 12 0.0003
801 VISUAL IMPAIRMENT 34 0.0003
802 IMPAIRED HEALING 9 0.0003
803 LIVER DISORDER 12 0.0003
804 SKIN HAEMORRHAGE 4 0.0003
805 RENAL INJURY 8 0.0003
806 HEPATIC FUNCTION ABNORMAL 10 0.0003
807 RESPIRATORY DISORDER 8 0.0003
808 HEPATIC CIRRHOSIS 5 0.0003
809 HEART RATE IRREGULAR 6 0.0003
810 HYPOAESTHESIA ORAL 4 0.0003
811 LACRIMATION INCREASED 8 0.0003
812 PRODUCT AVAILABILITY ISSUE 6 0.0003
813 BLOOD URINE PRESENT 5 0.0003
814 CARDIO-RESPIRATORY ARREST 11 0.0003
815 MUSCULOSKELETAL DISORDER 5 0.0003
816 CONVULSION 15 0.0003
817 MUSCLE TWITCHING 6 0.0003
818 DEVICE RELATED INFECTION 4 0.0003
819 EMOTIONAL DISORDER 8 0.0003
820 ANKLE FRACTURE 4 0.0003
821 TENDONITIS 4 0.0003
822 RENAL DISORDER 12 0.0003
823 EJECTION FRACTION DECREASED 4 0.0003
824 EAR PAIN 5 0.0003
825 BONE PAIN 15 0.0003
826 DYSGEUSIA 19 0.0003
827 SKIN LESION 7 0.0003
828 NEOPLASM MALIGNANT 17 0.0003
829 LYMPHADENOPATHY 9 0.0003
830 ARRHYTHMIA 12 0.0003
831 OCULAR HYPERAEMIA 12 0.0003
832 DIVERTICULITIS 7 0.0003
833 PULMONARY EMBOLISM 24 0.0003
834 SKIN BURNING SENSATION 18 0.0003
835 DIARRHOEA 160 0.0002
836 HYPOGLYCAEMIA 12 0.0002
837 MYALGIA 42 0.0002
838 RESPIRATORY FAILURE 18 0.0002
839 FIBROMYALGIA 6 0.0002
840 DRY MOUTH 20 0.0002
841 DEVICE BREAKAGE 10 0.0002
842 SWELLING FACE 16 0.0002
843 HERPES ZOSTER 14 0.0002
844 TOXICITY TO VARIOUS AGENTS 41 0.0002
845 INJECTION SITE WARMTH 5 0.0002
846 CHEST PAIN 45 0.0002
847 PHOTOSENSITIVITY REACTION 4 0.0002
848 DEVICE DIFFICULT TO USE 16 0.0002
849 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
850 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
851 SKIN DISORDER 8 0.0002
852 PALPITATIONS 28 0.0002
853 FACE OEDEMA 4 0.0002
854 HAEMATEMESIS 6 0.0002
855 HEMIPARESIS 4 0.0002
856 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
857 THROMBOCYTOPENIA 26 0.0002
858 HYPOACUSIS 10 0.0002
859 JOINT STIFFNESS 6 0.0002
860 SYRINGE ISSUE 4 0.0002
861 BURNING SENSATION 16 0.0002
862 HYPERKALAEMIA 8 0.0002
863 GASTRITIS 6 0.0002
864 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 46 0.0002
865 COLD SWEAT 4 0.0002
866 STEVENS-JOHNSON SYNDROME 5 0.0002
867 ISCHAEMIC STROKE 4 0.0002
868 GALLBLADDER DISORDER 4 0.0002
869 INJECTION SITE PRURITUS 15 0.0002
870 DYSPEPSIA 22 0.0002
871 JAUNDICE 6 0.0002
872 GOUT 4 0.0002
873 PAIN OF SKIN 6 0.0002
874 EXTRA DOSE ADMINISTERED 9 0.0002
875 FREQUENT BOWEL MOVEMENTS 6 0.0002
876 WHITE BLOOD CELL COUNT DECREASED 24 0.0002
877 MOOD ALTERED 6 0.0002
878 BONE DISORDER 4 0.0002
879 OSTEOPOROSIS 9 0.0002
880 APPLICATION SITE RASH 3 0.0002
881 SHOCK 5 0.0002
882 INJECTION SITE MASS 8 0.0002
883 DRUG ABUSE 18 0.0002
884 PLATELET COUNT DECREASED 23 0.0002
885 HEPATIC STEATOSIS 4 0.0002
886 WOUND 6 0.0002
887 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 10 0.0002
888 INJECTION SITE BRUISING 17 0.0002
889 BLINDNESS UNILATERAL 3 0.0002
890 RENAL FAILURE ACUTE 9 0.0002
891 INCREASED APPETITE 4 0.0002
892 CHOLESTASIS 4 0.0002
893 PANCREATITIS 11 0.0002
894 DEVICE LEAKAGE 9 0.0002
895 PRESCRIBED OVERDOSE 4 0.0002
896 DEATH 178 0.0002
897 INTENTIONAL PRODUCT MISUSE 18 0.0002
898 HAEMORRHOIDS 4 0.0002
899 CEREBRAL INFARCTION 5 0.0002
900 INCORRECT DOSE ADMINISTERED 46 0.0002
901 CEREBROVASCULAR ACCIDENT 34 0.0002
902 HAEMATOCHEZIA 11 0.0002
903 STOMATITIS 12 0.0002
904 ILL-DEFINED DISORDER 12 0.0002
905 TASTE DISORDER 4 0.0002
906 DIABETES MELLITUS 15 0.0002
907 DISCOMFORT 12 0.0002
908 EPILEPSY 6 0.0002
909 INJECTION SITE RASH 6 0.0002
910 ACUTE MYELOID LEUKAEMIA 3 0.0002
911 HYPERGLYCAEMIA 7 0.0002
912 COMA 9 0.0002
913 INJECTION SITE HAEMORRHAGE 15 0.0002
914 IMPAIRED WORK ABILITY 4 0.0002
915 RECTAL HAEMORRHAGE 8 0.0002
916 SKIN CANCER 4 0.0002
917 URTICARIA 31 0.0002
918 VISUAL ACUITY REDUCED 6 0.0002
919 TOOTH DISORDER 4 0.0002
920 RASH PAPULAR 4 0.0002
921 ANGER 6 0.0002
922 INJECTION SITE ERYTHEMA 22 0.0002
923 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
924 GASTRIC DISORDER 6 0.0002
925 LIVER FUNCTION TEST ABNORMAL 5 0.0002
926 INJECTION SITE SWELLING 13 0.0002
927 LABORATORY TEST ABNORMAL 5 0.0002
928 PRODUCT DOSE OMISSION 11 0.0002
929 CEREBRAL HAEMORRHAGE 6 0.0002
930 GASTROINTESTINAL HAEMORRHAGE 14 0.0002
931 BLOOD GLUCOSE DECREASED 8 0.0002
932 DRUG ADMINISTRATION ERROR 5 0.0002
933 BLOOD GLUCOSE ABNORMAL 3 0.0002
934 METABOLIC ACIDOSIS 5 0.0002
935 PRODUCT QUALITY ISSUE 21 0.0002
936 ACUTE KIDNEY INJURY 23 0.0002
937 EYE PRURITUS 5 0.0001
938 BONE MARROW FAILURE 3 0.0001
939 BLINDNESS 6 0.0001
940 DISEASE RECURRENCE 7 0.0001
941 RASH ERYTHEMATOUS 7 0.0001
942 RESPIRATORY ARREST 4 0.0001
943 OVERDOSE 31 0.0001
944 BLISTER 8 0.0001
945 INJURY 10 0.0001
946 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
947 PAIN IN JAW 4 0.0001
948 LEUKOPENIA 7 0.0001
949 DRUG EFFECT INCOMPLETE 5 0.0001
950 MYOCARDIAL INFARCTION 24 0.0001
951 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
952 DRY SKIN 18 0.0001
953 NERVOUS SYSTEM DISORDER 4 0.0001
954 BLOOD GLUCOSE INCREASED 24 0.0001
955 PRODUCT STORAGE ERROR 11 0.0001
956 HYPOTHYROIDISM 4 0.0001
957 INTENTIONAL OVERDOSE 8 0.0001
958 HAEMORRHAGE 13 0.0001
959 NIGHT SWEATS 4 0.0001
960 EMOTIONAL DISTRESS 15 0.0001
961 NEUTROPHIL COUNT DECREASED 5 0.0001
962 LUNG NEOPLASM MALIGNANT 5 0.0001
963 CARDIAC ARREST 10 0.0001
964 DISEASE PROGRESSION 14 0.0001
965 DEVICE USE ERROR 4 0.0001
966 NEOPLASM PROGRESSION 4 0.0001
967 DRUG DOSE OMISSION 19 0.0001
968 INJECTION SITE PAIN 35 0.0001
969 DERMATITIS ATOPIC 6 0.0001
970 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
971 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
972 PRODUCT ADHESION ISSUE 4 0.0001
973 BLOOD BILIRUBIN INCREASED 3 0.0001
974 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
975 SKIN IRRITATION 5 0.0001
976 BLOOD CHOLESTEROL INCREASED 5 0.0001
977 BREAST CANCER 9 0.0001
978 SKIN EXFOLIATION 8 0.0001
979 DRUG DEPENDENCE 15 0.0001
980 DEEP VEIN THROMBOSIS 6 0.0001
981 INJECTION SITE REACTION 6 0.0001
982 SKIN DISCOLOURATION 4 0.0001
983 EXPOSURE DURING PREGNANCY 5 0.0001
984 THERAPY CESSATION 4 0.0001
985 ECZEMA 4 0.0001
986 ABORTION SPONTANEOUS 3 0.0001
987 PANCYTOPENIA 4 0.0001
988 PSORIASIS 9 0.0001
989 NEUTROPENIA 9 0.0001
990 DEVICE EXPULSION 4 0.0001
991 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
992 NO ADVERSE EVENT 11 0.0001
993 BLADDER CANCER 3 0.0001
994 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
995 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000